Personalized Hepatic Disease Treatment and Management System

A comprehensive system integrating genomics, machine learning, and wearable technologies to provide tailored treatments and real-time monitoring for hepatic diseases, revolutionizing patient care and outcomes.

The original patent disclosed compositions and methods for treating hepatic diseases, but it lacked personalization and real-time monitoring capabilities. The new inventive concept addresses these limitations by incorporating genomics, machine learning, and wearable technologies to provide a holistic approach to hepatic disease management.

The system comprises a genomics-based diagnostic module that identifies a patient's specific genetic profile, a tailored therapeutic formulation adapted to the patient's genetic profile, and a wearable device for non-invasive monitoring of liver health. The system also includes a machine learning-based platform for optimizing therapeutic regimens and a 3D-bioprinted liver tissue model for testing and validating novel therapeutic formulations. The system's components interact to provide real-time feedback and recommendations for personalized treatment and lifestyle modifications.

The new claims introduce a paradigm shift in hepatic disease treatment by integrating genomics, machine learning, and wearable technologies to provide personalized and real-time monitoring capabilities. The inventive concept's novelty lies in its ability to adapt to individual patients' genetic profiles and provide tailored treatments, which is a significant departure from the original patent's composition-based approach.

Alternative embodiments may include using different types of biomarkers or sensors for monitoring liver health, or incorporating additional data sources, such as electronic health records or medical imaging data, to enhance the system's predictive capabilities. Variations may also include adapting the system for use in other disease areas, such as cancer or cardiovascular disease.

The inventive concept has significant commercial potential in the healthcare industry, particularly in the areas of personalized medicine, precision health, and digital health. The system's ability to provide real-time monitoring and tailored treatments could lead to improved patient outcomes, reduced healthcare costs, and increased market share for pharmaceutical and biotechnology companies.